| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 133 | 142 | 143 | 143 | 156 | 170 | 176 | 178 | 186 | 194 | 219 | 212 | 229 | 228 | 248 | 250 | 261 | 270 | 279 | 279 | 271 | 195 | 251 | 279 | 302 | 326 | 495 | 360 | 367 | 410 | 421 | 428 | 446 | 463 | 489 | 475 | 502 | 534 | 564 | 563 | 594 | 619 |
| Expenses | 115 | 123 | 127 | 125 | 131 | 144 | 149 | 150 | 153 | 162 | 180 | 180 | 191 | 198 | 213 | 222 | 231 | 228 | 238 | 234 | 236 | 176 | 218 | 245 | 343 | 272 | 292 | 342 | 302 | 336 | 345 | 349 | 365 | 386 | 402 | 391 | 403 | 435 | 451 | 470 | 480 | 505 |
| EBITDA | 19 | 19 | 17 | 18 | 25 | 26 | 28 | 28 | 34 | 32 | 39 | 32 | 38 | 30 | 34 | 28 | 30 | 43 | 42 | 45 | 35 | 19 | 33 | 34 | -41 | 55 | 202 | 18 | 65 | 74 | 76 | 78 | 80 | 76 | 87 | 84 | 100 | 99 | 112 | 93 | 114 | 114 |
| Operating Profit % | 13 % | 13 % | 11 % | 12 % | 15 % | 14 % | 15 % | 15 % | 16 % | 15 % | 15 % | 13 % | 14 % | 13 % | 13 % | 11 % | 10 % | 15 % | 14 % | 15 % | 12 % | 8 % | 12 % | 10 % | -16 % | 16 % | 17 % | 4 % | 17 % | 18 % | 18 % | 18 % | 17 % | 16 % | 17 % | 17 % | 18 % | 17 % | 18 % | 16 % | 18 % | 17 % |
| Depreciation | 10 | 11 | 11 | 11 | 12 | 13 | 14 | 15 | 15 | 15 | 17 | 18 | 21 | 20 | 21 | 22 | 23 | 34 | 35 | 38 | 42 | 39 | 40 | 42 | 38 | 38 | 38 | 41 | 41 | 40 | 41 | 41 | 42 | 41 | 43 | 44 | 46 | 47 | 50 | 57 | 58 | 58 |
| Interest | 9 | 9 | 9 | 10 | 11 | 5 | 6 | 5 | 7 | 7 | 10 | 10 | 15 | 18 | 24 | 13 | 16 | 31 | 35 | 36 | 36 | 37 | 27 | 29 | 26 | 26 | 23 | 24 | 24 | 25 | 26 | 27 | 26 | 26 | 27 | 30 | 27 | 34 | 36 | 41 | 44 | 46 |
| Profit Before Tax | 0 | 0 | -1 | -1 | 2 | 8 | 8 | 8 | 12 | 10 | 12 | 4 | 2 | -8 | -10 | -7 | -8 | -23 | -27 | -28 | -42 | -57 | -32 | -35 | -104 | -9 | 142 | -46 | 1 | 10 | 10 | 11 | 13 | 11 | 18 | 11 | 28 | 19 | 28 | -3 | 14 | 12 |
| Tax | 0 | -0 | -1 | 1 | -2 | 3 | 3 | 3 | 4 | 4 | 2 | 2 | 2 | -1 | -3 | -1 | 3 | -2 | -2 | 1 | 9 | -11 | -5 | -1 | 9 | 4 | 43 | 4 | -1 | 8 | 5 | 7 | 8 | 7 | 7 | 8 | 5 | 5 | 7 | -11 | 7 | 6 |
| Net Profit | 0 | 1 | -1 | -2 | 4 | 5 | 5 | 5 | 8 | 6 | 10 | 1 | -0 | -6 | -8 | -6 | -11 | -21 | -25 | -29 | -50 | -46 | -27 | -35 | -114 | -13 | 99 | -50 | 2 | 3 | 5 | 4 | 6 | 4 | 11 | 3 | 24 | 14 | 21 | 8 | 7 | 6 |
| EPS in ₹ | -0.04 | -0.07 | -0.23 | -0.30 | 0.44 | 0.59 | 0.58 | 0.63 | 0.90 | 0.55 | 1.17 | 0.37 | 0.30 | -0.39 | -0.74 | -0.71 | -0.99 | -2.05 | -2.51 | -2.57 | -4.91 | -4.48 | -1.94 | -2.33 | -8.14 | -0.76 | 8.22 | -3.55 | 0.43 | 0.44 | 0.53 | 0.54 | 0.60 | 0.55 | 0.97 | 0.41 | 1.53 | 0.87 | 1.29 | 0.50 | 0.53 | 0.34 |
Healthcare Global Enterprises
Healthcare Global Enterprises
733.55
+24.25
(3.42%)
Key Fundamentals
Market Cap
10,001.10 Cr
EPS
3.19
PE Ratio
250.98
Dividend Yield
0.00 %
Industry
Healthcare Services 52 Week High
718.00
52 Week Low
404.80
PB Ratio
11.18
Debt to Equity
1.78
Sector
Hospitals Analyst Rating and Forecast
- By Refinitiv from5 analysts
Actual
Company News
View All News
Aceso Company Pte. Ltd. sold 79,66,310 equity shares of HealthCare Global Enterprises Limited, representing approximately 5.65% of the company's total share capital. The transaction occurred through on-market sales over two days - 79,41,913 shares on September 10, 2025, and 24,397 shares on September 11, 2025. Following the sale, Aceso's holding in HealthCare Global Enterprises reduced from approximately 5.72% to 0.006%, retaining only 8,991 shares. The company disclosed this transaction under SEBI regulations for substantial acquisition of shares and takeovers. HealthCare Global Enterprises is listed on both the National Stock Exchange of India and BSE Limited.
HealthCare Global Enterprises Limited appointed Mr. Gopi Lama as Head of Domestic Sales, effective September 15, 2025. The appointment was approved by the Board of Directors based on the Nomination and Remuneration Committee's recommendation. Gopi Lama brings over 30 years of experience in the healthcare sector, including 13+ years in hospital operations. He has previously worked with leading organizations like Apollo, Fortis, Narayana Health, and SRCC Children's Hospital. His track record includes driving cluster revenues beyond INR 700 Cr and expertise in sales operations, brand strategy, consultant empanelment, and stakeholder engagement.
Morgan Stanley, Nippon India MF Lead Rs 438 Crore Share Purchase in HCG from CVC Capital
Sep 11, 2025
Sep 11, 2025Morgan Stanley, Nippon India Mutual Fund, Motilal Oswal MF, and Plutus Wealth Management collectively purchased 63 lakh equity shares of HealthCare Global Enterprises (HCG) worth Rs 438 crore through open market transactions. The buyers acquired a 4.52% stake at Rs 695 per share on the National Stock Exchange. CVC Capital Partners, through its affiliate Aceso Company Pte Ltd, sold these shares at the same price. Following this transaction, Aceso Company's holding in HCG decreased from 8.76% to 4.24%. HCG shares closed 1.31% lower at Rs 685.95. In February, KKR announced agreements to acquire up to 54% equity stake in HCG from CVC for approximately USD 400 million, making KKR the largest shareholder. HCG, founded in 1989, operates 25 medical care centres across 19 cities and is one of India's largest oncology hospital chains.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,202.70 | #1 1,14,266.90 | 101.89 | 7,184.10 | #1 28.68 | 1,076 | 30.34 | 60.77 | |
7,901.50 | 1,12,633.70 | 69.74 | #1 21,994.30 | 14.76 | #1 1,505 | 39.78 | 64.47 | |
1,084.90 | 82,686.80 | 90.81 | 7,849.70 | 13.25 | 809 | #1 53.33 | 68.38 | |
1,371.70 | 37,523.10 | 69.05 | 3,771.40 | 12.59 | 481 | 49.58 | 53.54 | |
702.45 | 36,234.80 | 104.27 | 4,286.70 | 15.12 | 337 | -98.18 | 65.62 | |
1,755.40 | 36,063.60 | #1 45.68 | 5,575.00 | 12.29 | 790 | -2.38 | 47.19 | |
719.90 | 29,362.20 | 71.28 | 3,067.00 | 21.98 | 415 | -10.71 | 49.37 | |
1,348.80 | 13,375.30 | 53.04 | 1,566.90 | 17.46 | 244 | 35.52 | 41.78 | |
1,544.00 | 10,034.20 | 52.47 | 1,290.20 | 17.77 | 194 | -1.57 | 59.98 | |
733.55 | #10 10,001.10 | #10 250.98 | #8 2,257.70 | #5 17.03 | #10 49 | #9 -55.88 | 71.60 |
Growth Rate
Revenue Growth
17.03 %
Net Income Growth
18.16 %
Cash Flow Change
11.43 %
ROE
3.14 %
ROCE
-5.78 %
EBITDA Margin (Avg.)
4.12 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 776 | 1,034 | 1,226 | 1,444 | 1,654 | 2,253 | 2,036 | 2,220 | 2,316 | 2,708 | 3,543 |
| Fixed Assets | 529 | 568 | 685 | 828 | 970 | 1,646 | 1,382 | 1,547 | 1,553 | 1,758 | 2,442 |
| Current Assets | 122 | 201 | 244 | 220 | 273 | 304 | 435 | 502 | 580 | 680 | 844 |
| Capital Work in Progress | 42 | 155 | 148 | 174 | 153 | 46 | 30 | 22 | 18 | 83 | 25 |
| Investments | 0 | 60 | 11 | 53 | 49 | 34 | 26 | 9 | 10 | 10 | 11 |
| Other Assets | 205 | 252 | 382 | 389 | 482 | 527 | 597 | 642 | 735 | 856 | 1,065 |
| Total Liabilities | 776 | 1,034 | 1,226 | 1,444 | 1,654 | 2,253 | 2,036 | 2,220 | 2,316 | 2,708 | 3,543 |
| Current Liabilities | 187 | 195 | 366 | 359 | 547 | 576 | 465 | 470 | 570 | 744 | 1,046 |
| Non Current Liabilities | 284 | 270 | 371 | 506 | 584 | 1,258 | 856 | 866 | 876 | 1,099 | 1,507 |
| Total Equity | 305 | 569 | 490 | 579 | 522 | 420 | 714 | 884 | 869 | 865 | 990 |
| Reserve & Surplus | 209 | 451 | 347 | 398 | 389 | 293 | 528 | 731 | 721 | 687 | 783 |
| Share Capital | 70 | 85 | 86 | 87 | 88 | 89 | 125 | 139 | 139 | 139 | 139 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 3 | 85 | -29 | -24 | -56 | -30 | 62 | 190 | -22 | -5 | -213 |
| Investing Activities | -79 | -204 | -210 | -283 | -238 | -101 | -171 | 125 | -133 | -226 | -488 |
| Operating Activities | 60 | 73 | 91 | 98 | 99 | 130 | 121 | 220 | 252 | 285 | 317 |
| Financing Activities | 22 | 216 | 89 | 161 | 84 | -58 | 112 | -155 | -140 | -64 | -42 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 70.71 % | 68.41 % | 68.40 % | 71.44 % | 71.43 % | 71.42 % | 71.39 % | 71.38 % | 71.37 % | 71.35 % | 71.30 % | 71.29 % | 71.28 % | 71.25 % | 71.23 % | 71.23 % | 71.22 % | 62.46 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 6.28 % | 0.00 % | 6.74 % | 3.95 % | 4.29 % | 2.77 % | 2.45 % | 2.16 % |
| DIIs | 7.82 % | 7.86 % | 6.27 % | 5.52 % | 4.90 % | 3.56 % | 4.03 % | 4.40 % | 5.54 % | 6.58 % | 7.94 % | 6.66 % | 8.52 % | 10.89 % | 11.64 % | 12.94 % | 12.47 % | 13.22 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 7.05 % | 9.46 % | 10.83 % | 10.07 % | 10.84 % | 11.58 % | 11.21 % | 11.60 % | 11.44 % | 10.43 % | 9.96 % | 9.68 % | 9.39 % | 9.41 % | 9.33 % | 9.60 % | 10.43 % | 10.50 % |
| Others | 14.42 % | 14.26 % | 14.50 % | 12.97 % | 12.83 % | 13.44 % | 13.38 % | 12.61 % | 11.65 % | 11.63 % | 4.52 % | 12.37 % | 4.07 % | 4.49 % | 3.50 % | 3.46 % | 3.43 % | 11.66 % |
| No of Share Holders | 13,891 | 15,065 | 20,573 | 22,362 | 23,663 | 23,018 | 24,672 | 28,707 | 28,858 | 25,931 | 27,327 | 27,289 | 27,195 | 26,529 | 29,670 | 32,820 | 45,394 | 47,028 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 25 Sept 2024 |  Annual General Meeting | NA | 25 Sept 2024 | 399.45 | 421.10 |
| 09 Nov 2024 |  Quarterly Result Announcement | NA | 09 Nov 2024 | 423.60 | 468.10 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 531.05 | 511.45 |
| 24 May 2025 | Quarterly Result Announcement | NA | 24 May 2025 | 549.50 | 592.15 |
| 01 Aug 2025 | Quarterly Result Announcement | NA | 01 Aug 2025 | 566.40 | 621.60 |
| 25 Sept 2025 | Annual General Meeting | NA | 25 Sept 2025 | 694.05 | 650.25 |
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20181 day ago
1 day agoClosure of Trading WindowSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 25, 2025
Sep 25, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Sep 15, 2025
Sep 15, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 13, 2025
Sep 13, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 12, 2025
Sep 12, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 12, 2025
Sep 12, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 04, 2025
Sep 04, 2025Reg. 34 (1) Annual Report.Sep 03, 2025
Sep 03, 2025Notice Of 27Th Annual General Meeting And Integrated Annual Report Of The Company For FY 2024-25.Sep 03, 2025
Sep 03, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 03, 2025
Sep 03, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 03, 2025
Sep 03, 2025Business Responsibility and Sustainability Reporting (BRSR)Sep 03, 2025
Sep 03, 2025Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Sep 02, 2025
Sep 02, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 02, 2025
Sep 02, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 22, 2025
Aug 22, 2025Updates on Open OfferAug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationAug 12, 2025
Aug 12, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotAug 12, 2025
Aug 12, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportAug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 02, 2025
Aug 02, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 01, 2025
Aug 01, 2025Appointment Of Secretarial And Cost Auditors Of The CompanyAug 01, 2025
Aug 01, 2025Results-Financial Results For Quarter Ended June 30 2025Aug 01, 2025
Aug 01, 2025Board Meeting Outcome for Outcome Of Board Meeting_August 01 2025Aug 01, 2025
Aug 01, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 23, 2025
Jul 23, 2025Announcement under Regulation 30 (LODR)-Meeting UpdatesJul 23, 2025
Jul 23, 2025Updates on Open OfferJul 18, 2025
Jul 18, 2025Announcement under Regulation 30 (LODR)-Open Offer - UpdatesJul 14, 2025
Jul 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 12, 2025
Jul 12, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotJul 11, 2025
Jul 11, 2025Announcement under Regulation 30 (LODR)-Open Offer - UpdatesJul 11, 2025
Jul 11, 2025Letter of OfferJul 10, 2025
Jul 10, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 10, 2025
Jul 10, 2025Board Meeting Intimation for Intimation Of The Meeting Of The Board Of Directors Scheduled On August 01 2025 To Consider And Approve Unaudited
Financial Results (Both Standalone And Consolidated) Of The Company For The Quarter Ended June 30 2025.Jul 07, 2025
Jul 07, 2025Closure of Trading WindowJun 30, 2025
Jun 30, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateJun 30, 2025
Jun 30, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJun 19, 2025
Jun 19, 2025Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Jun 10, 2025
Jun 10, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jun 10, 2025
Jun 10, 2025Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Jun 10, 2025
Jun 10, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jun 10, 2025
Jun 10, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJun 05, 2025
Jun 05, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 03, 2025
Jun 03, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jun 02, 2025
Jun 02, 2025Disclosures under Reg. 18(6) of SEBI (SAST) Regulations 2011Jun 02, 2025
Jun 02, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 30, 2025
May 30, 2025Mutual Fund Holdings
Nippon India Small Cap Fund Direct- Growth 
Axis Flexi Cap Fund Direct-Growth 
Tata Small Cap Fund Direct - Growth 
Motilal Oswal Balanced Advantage Fund Direct-Growth 
Bandhan Large & Mid Cap Fund Direct-Growth 
TRUSTMF Small Cap Fund Direct-Growth 
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth 
Samco Multi Cap Fund Direct-Growth 
Groww Nifty Total Market Index Fund Direct - Growth 
Angel One Nifty Total Market Index Fund Direct - Growth 
Mirae Asset Nifty Total Market Index Fund Direct-Growth Technical Indicators
RSI(14)
Neutral 71.60
ATR(14)
Volatile 24.50
STOCH(9,6)
Overbought 84.57
STOCH RSI(14)
Overbought 94.47
MACD(12,26)
Bullish 6.99
ADX(14)
Strong Trend 29.27
UO(9)
Bearish 65.02
ROC(12)
Uptrend And Accelerating 14.03
WillR(14)
Overbought -8.37
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
